Y-Intercept (HK)’s Whitehawk Therapeutics WHWK Stock Holding History

Y-Intercept (HK)’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-24,363	Closed	-$112K	–	2211
2026 Q2	$112K	Buy	+24,363	New	+$101K	﹤0.01%	1605
2024 Q3	–	Sell	-48,960	Closed	-$71.5K	–	1899
2024 Q2	$71.5K	Buy	+48,960	New	+$90.7K	﹤0.01%	1284

Other funds holding WHWK

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Y-Intercept (HK)'s WHWK Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Whitehawk Therapeutics (WHWK) in Q3 2026, closing a stake of 24,363 shares — an estimated $112K sold.

Y-Intercept (HK) first reported a position in WHWK in Q2 2024 and held it in 2 quarters. The position peaked at $112K in Q2 2026. 4 funds tracked by Wall St. Rank hold WHWK as of Q3 2026.

Y-Intercept (HK) reported no remaining Whitehawk Therapeutics position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 24,363 Whitehawk Therapeutics shares in Q3 2026, an estimated $112K.
Y-Intercept (HK) first reported a position in Whitehawk Therapeutics in Q2 2024 and held it in 2 quarters.
Y-Intercept (HK)'s Whitehawk Therapeutics position peaked at $112K in Q2 2026.
4 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.